• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 213/04 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom

Patent holdings for IPC class C07D 213/04

Total number of patents in this class: 239

10-year publication summary

18
14
17
25
13
12
22
17
12
3
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Novartis AG
10338
6
Merck Sharp & Dohme Corp.
2183
6
The Johns Hopkins University
5844
6
Nocion Therapeutics, Inc.
50
6
Boehringer Ingelheim International GmbH
4494
5
Gentex Corporation
1942
4
Axonis Therapeutics, Inc.
17
4
The Procter & Gamble Company
21919
3
The Regents of the University of California
20590
3
Canon Inc.
42633
3
Dow AgroSciences LLC
1194
3
Takeda Pharmaceutical Company Limited
2718
3
Vertex Pharmaceuticals Incorporated
1589
3
Purdue Research Foundation
3874
3
The Cleveland Clinic Foundation
1584
3
Dana-Farber Cancer Institute, Inc.
2645
3
Hutchison MediPharma Limited
106
3
Rohm and Haas Electronic Materials Korea Ltd.
332
3
Saudi Arabian Oil Company
13956
3
Shenzhen Chipscreen Biosciences Ltd.
25
3
Other owners 163